[HTML][HTML] Potential application of sucrose acetate isobutyrate, and glyceryl monooleate for nanonization and bioavailability enhancement of rivaroxaban tablets
This study aimed to investigate the use of Sucrose acetate isobutyrate (SAIB) and Glyceryl
monooleate (GMO) as co-formers for creating Cubosomes and SAIB-based nanodispersions …
monooleate (GMO) as co-formers for creating Cubosomes and SAIB-based nanodispersions …
Sucrose acetate isobutyrate (SAIB) and glyceryl monooleate (GMO) hybrid nanoparticles for bioavailability enhancement of rivaroxaban: an optimization study
AA Al-Shoubki, MH Teaima… - Pharmaceutical …, 2023 - Taylor & Francis
This study aims to improve the RXB bioavailability using hybrid nanoparticles. A modified
melt dispersion technique created different formulas with varying GMO-SAIB: RXB and GMO …
melt dispersion technique created different formulas with varying GMO-SAIB: RXB and GMO …
Novel rivaroxaban-loaded microsphere systems with different surface microstructure for enhanced oral bioavailability
MJ Choi, MR Woo, K Baek, JS Kim, JO Kim… - Drug Delivery and …, 2024 - Springer
This study compares rivaroxaban-loaded polymeric microsphere systems with three types of
surface microstructure. Three types of polymeric microspheres loaded with rivaroxaban were …
surface microstructure. Three types of polymeric microspheres loaded with rivaroxaban were …
Quality-by-design-based development of Rivaroxaban-Loaded Liquisolid Compact tablets with Improved Biopharmaceutical attributes
Rivaroxaban (RXN) finds use in the management of pulmonary embolism and deep vein
thrombosis. Its poor solubility (5–7 µg/mL) and P-gp-mediated efflux from intestinal lining …
thrombosis. Its poor solubility (5–7 µg/mL) and P-gp-mediated efflux from intestinal lining …
[PDF][PDF] Ameliorating the Poor Dissolution Rate of Selexipag in Aqueous Acidic Conditions Following Confinement into Mesoporous Silica
MS Attia, FES Ghazy - Ind. J. Pharm. Edu. Res, 2023 - researchgate.net
ABSTRACT Background: Pulmonary Arterial Hypertension (PAH) is a serious condition with
available treatment options, including Selexipag (SXP), a selective prostacyclin receptor …
available treatment options, including Selexipag (SXP), a selective prostacyclin receptor …
[PDF][PDF] BIOAVAILABILITY ENHANCEMENT STRATEGIES FOR RIVAROXABAN: A NOTEWORTHY REVIEW
This review article discusses Rivaroxaban (RXB), an anticoagulant that has gained much
attention due to its ability to prevent blood clots from forming in the body. However, one of …
attention due to its ability to prevent blood clots from forming in the body. However, one of …
[PDF][PDF] Pharmaceutical Science Advances
AA Al-Shoubki, MH Teaima, R Abdelmonem… - researchgate.net
This study aimed to investigate the use of Sucrose acetate isobutyrate (SAIB) and Glyceryl
monooleate (GMO) as co-formers for creating Cubosomes and SAIB-based nanodispersions …
monooleate (GMO) as co-formers for creating Cubosomes and SAIB-based nanodispersions …